VacZine Analytics  
Business opportunities are judged not only by their feasibility but also their ability to generate commercial return.

MarketVIEW is a vaccine forecast model. It is a comprehensive spreadsheet designed to give the most essential commercial readouts. Based on the clinical stage of the product opportunity, the competitive environment along with predicted product pricing and penetration it will provide a reference point to:

Predicted launch date(s)
Product volume estimates (mio doses)
Gross sales revenue estimates
Market share estimates
Sales revenue per segment/region estimates

*Some MarketVIEW products are accompanied by a detailed executive presentation.

Download our product brochure

CAT No: NAME: CONTENTS: DATE:
VAMV001 Clostridium difficile Click here> Nov '08
VAMV002 Staphylococcus aureus Click here> Mar '10
VAMV003 Chlamydia trachomatis Click here> Oct '08
VAMV004 *Pre-pandemic vaccines (H5N1) Click here> Mar '09
VAMV005 Chikungunya virus Click here> June '09
VAMV006 H1N1 vaccine - US forecast Click here> July '09
VAMV007 H1N1 vaccine - global forecast Click here> Sept '09
VAMV008 Group B Streptococcus Click here> Sept '09
VAMV009 Neisseria meningitidis ACWY Click here> Dec'09

More >>

For information on how to order e-mail: Info@vacZine-analytics.com

© 2009 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains